| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047878340 |
| P356 | DOI | 10.1186/S12885-015-1397-4 |
| P932 | PMC publication ID | 4435808 |
| P698 | PubMed publication ID | 25956431 |
| P5875 | ResearchGate publication ID | 276066344 |
| P50 | author | Beata Bode-Lesniewska | Q88127558 |
| P2093 | author name string | Bruno Fuchs | |
| Bernhard Robl | |||
| Sander Martijn Botter | |||
| Chantal Pauli | |||
| P2860 | cites work | A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 | Q24322196 |
| Maspin polymorphism associated with apoptosis susceptibility and in vivo tumorigenesis. | Q39951217 | ||
| VEGF expression as a prognostic marker in osteosarcoma | Q39961610 | ||
| Effect of chemotherapy on the mutation frequency of ovarian cancer cells at the HPRT locus. | Q40374170 | ||
| Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior | Q40534589 | ||
| The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis | Q40602468 | ||
| Immunohistochemical Estimates of Angiogenesis, Proliferative Activity, p53 Expression, and Multiple Drug Resistance Have No Prognostic Impact in Osteosarcoma: A Comparative Clinicopathological Investigation. | Q41973810 | ||
| Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy | Q44826148 | ||
| Prognostic significance of p53 expression in malignant bone tumors: a meta-analysis | Q46477265 | ||
| P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy | Q46477473 | ||
| Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. | Q48230264 | ||
| Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. | Q48334505 | ||
| Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas. | Q48584099 | ||
| Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma. | Q52619511 | ||
| Expression change of ezrin as a prognostic factor in primary osteosarcoma. | Q54410065 | ||
| Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma. | Q54653964 | ||
| Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells | Q24336533 | ||
| Maspin is not required for embryonic development or tumour suppression | Q24612315 | ||
| Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer | Q27824834 | ||
| p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. | Q27851827 | ||
| The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus | Q29619815 | ||
| The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data | Q30651861 | ||
| Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies | Q30724668 | ||
| Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma | Q30999677 | ||
| PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model | Q32069431 | ||
| Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program | Q33406382 | ||
| Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis | Q33531554 | ||
| Twenty years of p53 research: structural and functional aspects of the p53 protein | Q33807787 | ||
| Expression of mutant p53 protein in hepatocellular carcinoma | Q34378463 | ||
| Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. | Q34413741 | ||
| Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas | Q34447850 | ||
| Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. | Q34532932 | ||
| Osteosarcoma (osteogenic sarcoma). | Q34574274 | ||
| Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. | Q34611314 | ||
| CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients | Q35764430 | ||
| Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression | Q35791446 | ||
| Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. | Q35988850 | ||
| Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation | Q36115896 | ||
| Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer | Q36117164 | ||
| Prognostic value of nuclear maspin expression for adjuvant 5-fluorouracil-based chemotherapy in advanced gastric cancer | Q36224775 | ||
| Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors | Q36486421 | ||
| An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy | Q36610246 | ||
| The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma | Q37067646 | ||
| Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study | Q37380171 | ||
| Ki67 in breast cancer: prognostic and predictive potential | Q37691691 | ||
| Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma | Q37794441 | ||
| A meta-analysis of osteosarcoma outcomes in the modern medical era | Q38006949 | ||
| Mutational analysis of p53 in human tumors: immunocytochemistry | Q38451777 | ||
| Maspin influences response to doxorubicin by changing the tumor microenvironment organization. | Q39062271 | ||
| The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy | Q39733218 | ||
| Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort | Q39793825 | ||
| p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours. | Q54672464 | ||
| Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation | Q57274851 | ||
| Neoadjuvante Therapie des lokalisierten Osteosarkoms der Extremitäten | Q57339782 | ||
| Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs | Q57339791 | ||
| Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas | Q57966210 | ||
| Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q59586373 | ||
| Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's Sarcoma Family of Tumors | Q60050244 | ||
| A prognostic evaluation of vascular endothelial growth factor in children and young adults with osteosarcoma | Q61848887 | ||
| p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry | Q63446378 | ||
| Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables | Q69426532 | ||
| [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors] | Q70909544 | ||
| Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group | Q71975310 | ||
| Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis | Q73483291 | ||
| Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis | Q74099329 | ||
| PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy | Q74715361 | ||
| Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols | Q77579162 | ||
| Pre- and post-chemotherapy alkaline phosphatase levels as prognostic indicators in adults with localised osteosarcoma | Q81453409 | ||
| Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients | Q86922680 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 379 | |
| P577 | publication date | 2015-05-09 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy | |
| P478 | volume | 15 |
| Q50132881 | 2-Methoxyestradiol Reverses the Pro-Carcinogenic Effect of L-Lactate in Osteosarcoma 143B Cells |
| Q52847679 | Cytologic anaplasia is a prognostic factor in osteosarcoma biopsies, but mitotic rate or extent of spontaneous tumor necrosis are not: a critique of the College of American Pathologists Bone Biopsy template. |
| Q89622492 | Differential Outcomes and Biologic Markers of Radiation-Associated vs. Sporadic Osteosarcoma: A Single-Institution Experience |
| Q90338870 | Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma |
| Q50947610 | Molecular markers of DNA damage and repair in cervical cancer patients treated with cisplatin neoadjuvant chemotherapy: an exploratory study. |
| Q35826810 | Neoadjuvant chemotherapy (NCT) plus targeted agents versus NCT alone in colorectal liver metastases patients: A systematic review and meta-analysis |
| Q40633762 | Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance |
| Q55312849 | Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy. |
| Q38685591 | P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA. |
| Q90616566 | PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1 |
| Q96431810 | Promising abscopal effect of combination therapy with thermal tumour ablation and intratumoural OK-432 injection in the rat osteosarcoma model |
| Q92137525 | Sleeping Beauty Mouse Models of Cancer: Microenvironmental Influences on Cancer Genetics |
| Q38754899 | p16 protein expression and correlation with clinical and pathological features in osteosarcoma of the jaws: Experience of 37 cases. |
Search more.